Evolving Treatment Patterns for Hospitalized COVID-19 Patients in the United States in April 2020–July 2020

We sought to examine the trend (April–July) in the treatment patterns among hospitalized COVID-19 patients using the Premier Healthcare Database (PHD). In the analysis, we identified 53,264 patients from 302 hospitalsthat continuously provided inpatient data from April 1, 2020 to July 31, 2020 to th...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Xiaozhou, Johnson, Barbara H, Johnston, Stephen S, Elangovanraaj, Nivesh, Coplan, Paul, Khanna, Rahul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846837/
https://www.ncbi.nlm.nih.gov/pubmed/33531828
http://dx.doi.org/10.2147/IJGM.S290118
Descripción
Sumario:We sought to examine the trend (April–July) in the treatment patterns among hospitalized COVID-19 patients using the Premier Healthcare Database (PHD). In the analysis, we identified 53,264 patients from 302 hospitalsthat continuously provided inpatient data from April 1, 2020 to July 31, 2020 to the PHD, a nationwide, population-based multihospital research database in the US. We used generalized estimating equations (GEE) models to assess changes in the proportion of therapies used during the study period. After adjusting for patient and provider factors, a decline in hydroxychloroquine and an increase in azithromycin and dexamethasone were observed among COVID-19 patients during the 4-month study period.

Ejemplares similares